They identified an elevated plasma level of anti-CD74 from two patients with CIP in a discovery cohort and subsequently verified a 1.34-fold increase from 10 patients with CIP in a confirmation cohort. This evidence concerns the gene CD74 and hereditary sensory and autonomic neuropathy.